Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1190309-69-3 | MDL No. : | MFCD12962898 |
Formula : | C8H4BrN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZEGVAWKWFXUSRV-UHFFFAOYSA-N |
M.W : | 222.04 | Pubchem ID : | 53412566 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 48.51 |
TPSA : | 52.47 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.43 cm/s |
Log Po/w (iLOGP) : | 1.52 |
Log Po/w (XLOGP3) : | 1.72 |
Log Po/w (WLOGP) : | 2.2 |
Log Po/w (MLOGP) : | 1.09 |
Log Po/w (SILICOS-IT) : | 2.64 |
Consensus Log Po/w : | 1.83 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.86 |
Solubility : | 0.31 mg/ml ; 0.0014 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.44 |
Solubility : | 0.81 mg/ml ; 0.00365 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.86 |
Solubility : | 0.0309 mg/ml ; 0.000139 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.78 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
73% | With 4-dimethylaminopyridine; triethylamine In dichloromethane at 20℃; for 15h; | A Step A. 3-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile. To a flask containing 3-bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile (500 mg, 2.25 mmol), DMAP (55 mg, 0.45 mmol), triethylamine (0.94 ml, 6.8 mmol), and dichloromethane (15 mL) was added TosCI (515 mg, 2.70 mmol). The resultant mixture was stirred at room temperature for 15 h, then diluted with H2O (50 mL) and extracted with dichloromethane (50 mL x 3). The combined organic solvent extracts were dried over anhydrous Na2SO4 filtered, and concentrated to dryness under reduced pressure to yield the product, which was purified by FCC (eluent: petroleum ether: ethyl acetate = 1 :0 to 5:1 ) to yield 3-bromo-1-tosyl-1H- pyrrolo[2,3-b]pyridine-5-carbonitrile (680 mg, 73%) as a white solid. LCMS (ESI): mass calcd. for C15H10BrN3O2S, 376.22; m/z found, 378.0 |
73% | With 4-dimethylaminopyridine; triethylamine In dichloromethane at 20℃; for 15h; | A Step A. 3-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile. To a flask containing 3-bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile (500 mg, 2.25 mmol), DMAP (55 mg, 0.45 mmol), triethylamine (0.94 ml, 6.8 mmol), and dichloromethane (15 mL) was added TosCI (515 mg, 2.70 mmol). The resultant mixture was stirred at room temperature for 15 h, then diluted with H2O (50 mL) and extracted with dichloromethane (50 mL x 3). The combined organic solvent extracts were dried over anhydrous Na2SO4 filtered, and concentrated to dryness under reduced pressure to yield the product, which was purified by FCC (eluent: petroleum ether: ethyl acetate = 1 :0 to 5:1 ) to yield 3-bromo-1-tosyl-1H- pyrrolo[2,3-b]pyridine-5-carbonitrile (680 mg, 73%) as a white solid. LCMS (ESI): mass calcd. for C15H10BrN3O2S, 376.22; m/z found, 378.0 |
60% | Stage #1: 3-bromo-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile With sodium hydride In tetrahydrofuran; mineral oil at 0℃; for 1h; Stage #2: 4-methylbenzene-1-sulfonyl chloride In tetrahydrofuran; mineral oil at 20℃; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1.1: sodium hydride / tetrahydrofuran; mineral oil / 1 h / 0 °C 1.2: 20 °C 2.1: zinc; iodine / N,N-dimethyl-formamide / 0.58 h / 20 °C 2.2: 3 h / 55 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: 4-dimethylaminopyridine; triethylamine / dichloromethane / 15 h / 20 °C 2: anhydrous potassium acetate; palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride / 1,4-dioxane / 16 h / 85 °C / Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 3 steps 1: 4-dimethylaminopyridine; triethylamine / dichloromethane / 15 h / 20 °C 2: anhydrous potassium acetate; palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride / 1,4-dioxane / 16 h / 85 °C / Inert atmosphere 3: palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride; Cs2CO3 / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 4-dimethylaminopyridine; triethylamine / dichloromethane / 15 h / 20 °C 2: anhydrous potassium acetate; palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride / 1,4-dioxane / 16 h / 85 °C / Inert atmosphere 3: palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride; Cs2CO3 / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere 4: tripotassium phosphate tribasic; dichloro[ 1,1’-bis(di-tert-butylphosphino)ferrocene]palladium (II) / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: 4-dimethylaminopyridine; triethylamine / dichloromethane / 15 h / 20 °C 2: anhydrous potassium acetate; palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride / 1,4-dioxane / 16 h / 85 °C / Inert atmosphere 3: palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride; Cs2CO3 / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere 4: tripotassium phosphate tribasic; dichloro[ 1,1’-bis(di-tert-butylphosphino)ferrocene]palladium (II) / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 5 steps 1: 4-dimethylaminopyridine; triethylamine / dichloromethane / 15 h / 20 °C 2: anhydrous potassium acetate; palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride / 1,4-dioxane / 16 h / 85 °C / Inert atmosphere 3: palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride; Cs2CO3 / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere 4: tripotassium phosphate tribasic; dichloro[ 1,1’-bis(di-tert-butylphosphino)ferrocene]palladium (II) / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere 5: sodium hydroxide; lithium hydroxide monohydrate / 1,4-dioxane / 1 h / 60 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 5 steps 1: 4-dimethylaminopyridine; triethylamine / dichloromethane / 15 h / 20 °C 2: anhydrous potassium acetate; palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride / 1,4-dioxane / 16 h / 85 °C / Inert atmosphere 3: palladium (II) [1,1'-bis(diphenylphosphanyl)ferrocene] dichloride; Cs2CO3 / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere 4: tripotassium phosphate tribasic; dichloro[ 1,1’-bis(di-tert-butylphosphino)ferrocene]palladium (II) / 1,4-dioxane; lithium hydroxide monohydrate / 1 h / 85 °C / Microwave irradiation; Inert atmosphere 5: sodium hydroxide; lithium hydroxide monohydrate / 1,4-dioxane / 1 h / 60 °C |
[ 74420-15-8 ]
3-Bromo-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.89
[ 281192-91-4 ]
3-Bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.86
[ 183208-35-7 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.85
[ 183208-54-0 ]
1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine
Similarity: 0.83
[ 183208-22-2 ]
5-Bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.82
[ 517918-95-5 ]
1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile
Similarity: 0.83
[ 1159982-14-5 ]
4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonitrile
Similarity: 0.81
[ 1190317-45-3 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile
Similarity: 0.74
[ 4414-87-3 ]
2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)acetonitrile
Similarity: 0.73
[ 74420-15-8 ]
3-Bromo-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.89
[ 281192-91-4 ]
3-Bromo-1-methyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.86
[ 183208-35-7 ]
5-Bromo-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.85
[ 517918-95-5 ]
1H-Pyrrolo[2,3-b]pyridine-5-carbonitrile
Similarity: 0.83
[ 183208-54-0 ]
1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine
Similarity: 0.83